Margareta Wiken
Overview
Explore the profile of Margareta Wiken including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
59
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Harmatz P, Muenzer J, Ezgu F, Dalen P, Huledal G, Lindqvist D, et al.
Mol Genet Metab
. 2022 Jul;
136(4):249-259.
PMID: 35835061
Purpose: Mucopolysaccharidosis IIIA (MPS IIIA) is an inherited lysosomal storage disorder caused by mutations in the N-sulfoglucosamine sulfohydrolase gene that result in deficient enzymatic degradation of heparan sulfate (HS), resulting...
2.
Saag K, Khanna P, Keenan R, Ohlman S, Osterling Koskinen L, Sparve E, et al.
Arthritis Rheumatol
. 2021 Feb;
73(8):1533-1542.
PMID: 33605029
Objective: To evaluate the efficacy and safety of anakinra compared to triamcinolone in the treatment of gout flares. Methods: Patients for whom nonsteroidal antiinflammatory drugs and colchicine were not suitable...
3.
Sommer J, Sadeghi-Khomami A, Barnowski C, Wiken M, Willemze A
Int J Lab Hematol
. 2020 Mar;
42(3):350-358.
PMID: 32202380
Introduction: Monitoring of factor IX (FIX) replacement therapy in haemophilia B relies on accurate coagulation assays. However, considerable interlaboratory variability has been reported for one-stage clotting (OSC) assays. This study...
4.
Wiken M, Hallen B, Kullenberg T, Osterling Koskinen L
Clin Rheumatol
. 2018 Jul;
37(12):3381-3386.
PMID: 29982913
Anakinra is an effective, well-tolerated, long-term anti-inflammatory treatment for cryopyrin-associated periodic syndromes (CAPS), yet evidence shows that it can induce the development of anti-drug antibodies (ADA). This analysis aims to...
5.
Frandsen T, Naested H, Rasmussen S, Hauptig P, Wiberg F, Rasmussen L, et al.
Biotechnol Bioeng
. 2011 Apr;
108(9):2171-81.
PMID: 21495017
The beneficial effect of antibody therapy in human disease has become well established mainly for the treatment of cancer and immunological disorders. The inherent monospecificity of mAbs present limitations to...
6.
Wiken M, Sjoberg K
Semin Thromb Hemost
. 2002 Jul;
28(3):297-308.
PMID: 12098092
ReFacto lacks the major part of the B-domain, except for 14 amino acid residues from the N-terminal and C-terminal ends, which are linked into a 14 amino acid SQ-peptide tail...